Stay updated on Carfilzomib Combo for Myeloma Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib Combo for Myeloma Clinical Trial page.

Latest updates to the Carfilzomib Combo for Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has updated its version from v2.15.0 to v2.15.2 and has added new dates in April 2025 while removing older dates from March 2025.SummaryDifference0.6%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has been updated to include a new trial involving Daratumumab for Multiple Myeloma, while significant details about a previous trial and its eligibility criteria have been removed.SummaryDifference39%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 20, 2025.SummaryDifference0.2%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference1%
Stay in the know with updates to Carfilzomib Combo for Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib Combo for Myeloma Clinical Trial page.